Topical co-enzyme Q 10 formulations and its application method

Topical co-enzyme Q 10 formulations and its application method

  • CN 102,258,503 B
  • Filed: 01/21/2005
  • Issued: 08/16/2019
  • Est. Priority Date: 01/22/2004
  • Status: Active Grant
First Claim
Patent Images

1. the composition comprising 0.01% to the 30%w/w Co-Q10 as sole active agent is used for treating cancer in preparationDrug in purposes, wherein the cancer be selected from melanoma, squamous cell carcinoma, liver cancer and osteosarcoma.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×